Memory Problems Linked to Slower Rate of Decline in Alzheimer’s

June is Alzheimer’s and Brain Awareness Month. Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia.

Translate to Spanish or other 102 languages!

Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia. Image for illustration purposes
Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia. Image for illustration purposes

Mega Doctor News

- Advertisement -

CLEVELAND CLINIC – June is Alzheimer’s and Brain Awareness Month.

Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia.

“What we found out was that people with early memory symptoms alone compared to people with early language problems or visual-spatial problems, they tend to have a slightly slower disease progression in terms of their functional abilities,” explained Jagan Pillai, MD, neurologist for Cleveland Clinic and lead author on the study.

- Advertisement -

Dr. Pillai said those with language problems, spatial ability and judgment issues seemed to be affected more over a period of time – specifically in their daily functional abilities.

He said it seems to make sense since a person with just memory difficulties could find other ways to compensate, like keeping track of what they’re doing by recording themselves or writing down notes. That would then allow them to remain functional.

He also noted that memory difficulties come from another part of the brain than language problems, for example. So, how the disease progresses could be different.

“The portion of the brain that is first impacted by the disease tends to determine the symptoms that goes along with the disease and also the kind of progression from there to other regions,” said Dr. Pillai.

- Advertisement -

Dr. Pillai said having this information available can better help physicians diagnose people and prepare them for the future.

It can also be useful for researchers when it comes to testing different medications to treat Alzheimer’s disease.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.

STHS to Raise Awareness of PTSD in Latest South Texas Healthy Living Episode, June 28th

If you’re experiencing intrusive, distressing memories or feeling constantly on edge following a traumatic event, you may be living with post-traumatic stress disorder (PTSD) and you’re not alone. 

STHS Highlights Life-Saving Habits for Men

While men face unique health challenges, experts say routine preventive care, healthy lifestyle habits and early intervention can significantly improve health outcomes and overall quality of life.

Health Experts Issue Comprehensive Roadmap to Reduce Kids’ Sugar Intake

American children consume more than double the recommended amount of added sugars each day, contributing to rising rates of childhood obesity, type 2 diabetes, and other chronic health conditions.
- Advertisement -